ICURe Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Investments
  • 228

  • Portfolio
  • 189

  • Exits
  • 26

Exits

ICURe General Information

Company Description

Founded in 2013, ICURe is an accelerator firm based in London, United Kingdom. The firm prefers to accelerate seed-stage and early-stage companies operating in business-to-business, commercial services, life sciences, cleantech, climate tech, health tech, and technology sectors.

Business Details

Website
icureprogramme.com
Year Founded
2013
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Corporate Office
  • Unit 220, Business Design Centre
  • Upper Street, Islington
  • London N1 0QH
  • England, United Kingdom

ICURe Investments (228)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Avigen (Drug Discovery) 01-Apr-2025 Grant Drug Discovery Generating Revenue
MORF Bio 01-Mar-2025 Other Software Generating Revenue
Reactive Fusion 19-Feb-2025 Industrial Supplies and Parts Startup
Less Grey Imaging 28-Jan-2025 Diagnostic Equipment Generating Revenue
Hychor 22-Oct-2024 Energy Production Generating Revenue
Northern Light Microscopy 01-Oct-2024 Electronic Equipment and Instruments Generating Revenue
Xmoor 22-Jul-2024 Business/Productivity Software Startup
KLAS Therapeutics 14-May-2024 Biotechnology Generating Revenue
Metzero Technologies 01-May-2024 Accelerator/Incubator Environmental Services (B2B) Product Development
MiDx 29-Jan-2024 Accelerator/Incubator Diagnostic Equipment Generating Revenue
You’re viewing 10 of 228 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ICURe Exits (26)

Company Name Exit Date Exit Type Exit Size
TrueDeploy 07-Jul-2026 Out of Business
AccelerComm 01-Jun-2026
Interface Polymers 25-Apr-2026
Ceryx Medical 01-Apr-2026
3finery 29-Mar-2026
KETS 01-Mar-2026
ThioTech 06-Nov-2025
HAI TECH 04-Nov-2025
Green Bioactives 03-Nov-2025 Out of Business
CryoLogyx 05-Oct-2025 Out of Business
You’re viewing 10 of 26 exits. Get the full list »

ICURe Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

ICURe FAQs

  • What is ICURe?

    Founded in 2013, ICURe is an accelerator firm based in London, United Kingdom.

  • When was ICURe founded?

    ICURe was founded in 2013.

  • Where is ICURe headquartered?

    ICURe is headquartered in London, United Kingdom.

  • How many investments has ICURe made?

    ICURe has made 228 investments.

  • What has ICURe invested in?

    ICURe has made numerous investments in companies like Avigen (Drug Discovery), MORF Bio, and Reactive Fusion within the Drug Discovery, Software, and Industrial Supplies and Parts industries.

  • What has ICURe invested in recently?

    ICURe's latest investment was on 01-Apr-2025 in Avigen (Drug Discovery), a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process